NeoGenomics, Inc.

NEONASDAQ • USD
ThemeHealthcare - Oncology›Cancer Diagnostics & Biomarkers
16.59 USD
↗ 0.20 (1.22%)AT CLOSE (03:59 PM EDT)
16.59
↘ 0.01 (0.03%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
16.59
↘ 0.01 (0.03%)
🔴Market: CLOSED

NeoGenomics, Inc. (NEO) is currently trading at $16.59. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, NEO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 23, 2026.

Open?$16.36
High?$16.76
Low?$16.07
Prev. Close?$16.39
Volume?1.4M
Avg. Volume?2.3M
VWAP?$16.50
Rel. Volume?0.63x
Bid / Ask
Bid?$13.33 × 100
Ask?$19.11 × 100
Spread?$5.78
Midpoint?$16.22
Valuation & Ratios
Market Cap?2.1B
Shares Out?128.5M
Float?125.9M
Float %?98.0%
P/E Ratio?N/A
P/B Ratio?2.71
EPS?-$0.40
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Themes
Healthcare - Oncology›Cancer Diagnostics & BiomarkersHealthcare - Genomics & Precision Medicine›Genetic Testing & Diagnostics
Employees
2.5K
Market Cap
2.1B
Industry
SERVICES-TESTING LABORATORIES
Website
www.neogenomics.com
Listed
1996-01-25
Address
9490 NEOGENOMICS WAY
FORT MYERS, FL 33912
Phone: (239) 768-0600
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
90
Momentum?
88
Short Sent.?
70
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.87Safe
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.24%High
Short Interest?14.2M
Days to Cover?5.7
Free Float125.9M
Avg Daily Volume2.5M
Settlement Date2026-09-30
Financial Health
Current Ratio?3.60Strong
Quick Ratio?3.35Strong
Cash Ratio?1.37Strong
Debt/Equity?0.48Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
60
2.71CHEAP▾
P/S?
Peers
100
S&P
54
2.78CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
3
500.5HIGH▾
EV/Sales?
Peers
100
S&P
59
3.09FAIR▾
Returns & Efficiency
ROE?
S&P
10
-6.6%WEAK▾
ROA?
S&P
3
-3.8%WEAK▾
Cash Flow & Enterprise
FCF?$-7355000
Enterprise Value?$2.4B
Fundamentals ratios updated end of day
MarketsMoversWatchlist